CAI CARIS LIFE SCIENCES, INC.
Research report · from SEC EDGAR · close 2026-07-13
$17.06 +0.4%
$4.82B mkt cap
executive summary
CARIS LIFE SCIENCES, INC. (CAI) is a $4.82B company. Revenue is $812.0M (+97.0% y/y) at a -8% net margin. It is not yet profitable. Our health score is C (66/100). No major red flags on file. Smart money is buying (2 insider, 1 funds). It funds itself; low dilution risk.
Revenue (FY)
$812.0M
+97.0% y/y
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
2 / 0
Cash & ST investments
$822.2M
Operating cash flow
$83.2M
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.